SCHEMBL7602285

SCHEMBL7602285

CCCOCCCNc1ccc(C(=C(CC)Cc2ccccc2)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.41
SCN5A Q14524 2/20 0.40
ABCB11 O95342 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2B P18089 1/20 0.40
OPRD1 P41143 1/20 0.40
NAMPT P43490 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP19A1 P11511 1/20 0.38
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.36
MAOA P21397 1/20 0.36
CNR1 P21554 1/20 0.36
DRD4 P21917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7602281 1.00 ESR1 (0.41) ESR1SCN5AABCB11CYP3A4ADRA2B
SCHEMBL7600809 0.93 ESR1 (0.43) ESR1SCN5AABCB11CYP3A4ADRA2B
SCHEMBL7602304 0.93 ESR1 (0.43) ESR1SCN5AABCB11CYP3A4ADRA2B
SCHEMBL7598596 0.92 SMN1; SMN2 (0.43) ESR1NAMPTALDH1A1HPGDSMN1; SMN2
SCHEMBL7596104 0.92 SMN1; SMN2 (0.43) ESR1NAMPTALDH1A1HPGDSMN1; SMN2
SCHEMBL7600851 0.88 ESR1 (0.43) ESR1SCN5AABCB11CYP3A4ADRA2B
SCHEMBL7597702 0.88 ESR1 (0.43) ESR1SCN5AABCB11CYP3A4ADRA2B
SCHEMBL7599042 0.84 ESR1 (0.43) ESR1NAMPTHPGDSMN1; SMN2CYP19A1
SCHEMBL7599046 0.84 ESR1 (0.43) ESR1NAMPTHPGDSMN1; SMN2CYP19A1
SCHEMBL7603604 0.84 ESR1 (0.41) ESR1ALDH1A1CYP19A1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161007-A1 Non-steroidal modulators of estrogen receptors PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161007-A1 Non-steroidal modulators of estrogen receptors ESRRB, ESR2, ESRRG ESR1 6/4885SCN5A 4662/4885ABCB11 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.